Comparison of progenitor cell collection on day 4 or day 5 after steady- state stimulation with G-CSF alone in breast cancer patients' influence on CD34+ cell yield, subpopulation, and breast cancer cell contamination

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 1, 2000, Pages 111-117

  Kröger, Nicolaus ^a,b   Krüger, William ^a   Renges, Helmut ^a   Zeller, Wolfgang ^a   Rauhöft, Claudia ^a   Löliger, Cornelius ^a   Zander, Axel R ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAXANE DERIVATIVE; THIOTEPA;

ADULT; AGED; APHERESIS; ARTICLE; BREAST CANCER; CELL COUNT; CELL SUBPOPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTAMINATION; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; PRIORITY JOURNAL;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; BLOOD COMPONENT REMOVAL; BREAST NEOPLASMS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE COUNT; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; NAD+ NUCLEOSIDASE; PROSPECTIVE STUDIES; STEM CELLS; TIME FACTORS;

EID: 1642633606     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319694     Document Type: Article

References (26)

1. Bensinger WI, K Longin, F Appelbaum, S Rowley, C Weaver, K Lilleby, T Gooley, M Lynch, T Higano, J Klarnet, T Chauncey, R Storb and CD Buckner. (1994). Peripheral blood stem cells collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825-831.
2. To LB, MM Roberts, DN Haylock, GG Dyson, AL Branford, D Thorp, JQK Ho, GW Dart, N Horvath, MLJ Davy, CLM Olweny, E Abdi and CA Juttner. (1992). Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral stem cell transplants, autologous bone marrow transplants and allogenic bone marrow transplants. Bone Marrow Transplant 9:277-284.
3. Sheridan WP, CG Begley, CA Juttner, J Szer, LB To, D Maher, KM McGrath, G Morstyn and RM Fox. (1992). Effeet of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644.
4. Antmann K, I Ayash, K Elias, C Wheeler, M Hunt, JP Eder, BA Teicher, JJ Critchlow, J Bibbo, LE Schnipper and E Frei. (1992). A phase II study of high-dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J Clin Oncol 10: 102-110.
5. Bezwoda WR, L Seymour and RD Dansey. (1995). High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 13:2483-2489.
6. Schwartzberg L, R Birch, R Blanco, F Wittlin, J Muscato, K Tauer, B Hazelton and W West. (1993). Rapid and sustained hematopoietic reconstitution by peripheral stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 11:369-374.
7. Chao NJ, JR Schriber, K Grimes, GD Long, RS Negrin, CM Raimondi, SJ Horning, SL Brown, L Miller and KG Blume. (1993). Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031-2035.
8. Kröger N, W Zeller, N Fehse, HT Hassan, W Krüger, K Gutensohn, C Löliger and AR Zander. (1998). Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Br J Haematol 102:1101-1106.
9. Nadamanee A, J Sniecinski, GM Schmidt, AC Dagis, MR O'Donnell, DS Snyder, PM Parker, AS Stein, EP Smith, A Molina, DE Stepan, G Somlo, KA Margolin, D Woo, JC Miland and SJ Forman. (1994). High-dose therapy followed by autologous peripheral blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral stem cells. J Clin Oncol 12:2176-2186.
10. Demirer T, CD Buckner, B Storer, K Lilleby, S Rowley, R Clift, FR Appelbaum, R Storb and WI Bensinger. (1997). Effect of different chemotherapy regimens on peripheral blood stem cell collection in patients with breast cancer receiving granulocyte colony-stimulating factor. J Clin Oncol 15:684-690.
11. Copelan EA, SK Ceselski, SA Ezzone, LC Lasky, SL Penza, TP Bechtel, JL Klein, DM Hehmeyer, MD Scholl, DD Marshall, PJ Elder, GL Risley and BR Avalos. (1997). Mobilization of peripheral blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factors in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease. J Clin Oncol 15:759-765.
12. Bensinger WI, FR Appelbaum, S Rowley, R Storb, J Sanders, K Lilleby, T Gooley, T Demirer, K Schiffmann, C Weaver, R Clift, T Chauncey, J Klarnet, P Montgomery, S Petersdorf, P Weiden, R Witherspoon, and CD Buckner. (1995). Factors that influence collection and engraftement of autologous peripheral stem cell. J Clin Oncol 13: 2547-2555.
13. Weaver CH, B Hazelton, R Birch, P Palmer, C Allen, L Schwartzberg and W West. (1996). An analysis of engraftement kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after administration of myeloablative chemotherapy. Blood 86:3961-3969.
14. Kroger N, W Zeller, HT Hassan, W Krüger, K Gutensohn, C Löliger and AR Zander. (1999). Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 × 5 μg/kg) compared to single dose (1 × 10 μg/kg). Bone Marrow Transplant 23:125-129.
15. Desikan KR, B Barlogie, S Jagannath, DH Vesole, D Siegel, A Fassas, N Munshi, S Singhel, J Mehta, S Tindle, J Nelson, D Bracy, S Mattox and G Tricot. (1998). Comparable engraftment kinetics following peripheral blood stem cell infusion mobilized with G-CSF with or without cyclophosphamide in multiple myeloma. J Clin Oncol 16:1547-1553.
16. Zeller W, K Gutensohn, M Stockschläder, J Dierlamm, N Kröger, G Köhne, K Hummel, H Kabisch, HJ Weh, P Kühnl, DK Hossfeld and AR Zander. (1996). Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplant 17:709-713.
17. Hassan HT, W Zeller, M Stockschläder, B Biermann and AR Zander. (1996). Comparison between bone marrow and G-CSF mobilized blood allograft undergoing clinical scale CD34 positive cell selection. Stem Cells 14:419-429.
18. + cell determination by flow cytometry. J Hematother 5:213.
19. Jung R, W Krüger, S Hosch, M Holweg, N Kröger, C Wagner, M Neumaier and AR Zander. (1998). Specificity of rt-PCR assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 78:1194-1998.
20. Dreger P, T Haferlach, V Eckstein, S Jacobs, M Suttorp, H Löffler, W Müller-Ruchholtz and N Schmitz. (1994). G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft. Br J Haematol 87:609-613.
21. Grigg AP, AW Roberts, H Raunow, S Houghton, JE Layton, AW Boyd, KM McGrath and Maher. (1995). Optimizing dose and scheduling of filgrastim for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437-4445.
22. + progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol 93:930-942.
23. - cells in early and late trilineage haematopoietic engraftment after autologous blood cell transplantation. Br J Haematol 103:568-581.
24. Traystman MD, GT Cochran, SJ Hake, CA Kuszynski, SI Mann, BJ Murphy, SJ Pirrucello, E Zuvanich and JG Sharp. (1997). Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells. J Hematother 6:551-561.
25. Passos-Coelho J, AA Ross, DJ Kahn, T Moss, JM Davis, AM Huelskamp, SJ Noga, NE Davidson and MJ Kennedy. (1996). Similar breast cancer cell contamination of single-day peripheral blood progenitor cell collections obtained after priming with hematopoietic growth factor alone after cyclophosphamde followed by growth factor. J Clin Oncol 14:2569-2579.
26. Luider J, C Brown, S Selinger, D Quinlan, L Karlsson, D Ruether, D Stewart, J Klassen and JA Russell. (1997). Factors influencing yield of progenitor cells for allogeneic transplantation: optimizing of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother 6: 575-580.